News | Artificial Intelligence | May 31, 2019

Intelerad Commits $75 Million to R&D for New AI and Cloud-based Medical Imaging Software

Funding will back efforts such as Clairvoyance productivity dashboard for real-time, data-driven decision-making in radiology

Intelerad Commits $75 Million to R&D for New AI and Cloud-based Medical Imaging Software

May 31, 2019 — Intelerad Medical Systems announced a $75 million investment in research and development (R&D) to expand its solutions portfolio, with an emphasis on cloud technology and artificial intelligence (AI) solutions.

On a daily basis, Intelerad solutions enable radiologists to perform more than 200,000 diagnostic interpretations worldwide. The company’s $75 million investment and ongoing focus on creating innovative solutions for a global customer base is expected to fuel a twofold increase in study volume. Intelerad technology simplifies everyday tasks for radiologists and other healthcare professionals, enabling them to optimize efficiency and apply their expertise and energy toward more personalized services and follow-ups for every patient.

With an emphasis on cloud technology and AI, Intelerad is focused on providing software-as-a-Service (SaaS) solutions for healthcare. For example, the cloud-based Clairvoyance productivity dashboard will incorporate machine learning technology to provide predictive insights to imaging departments, enabling real-time, data-driven decisions that contribute to higher-quality, more timely care and better outcomes for patients.

Over the last three years, Intelerad has expanded its employee base by 30 percent. The company expects to double in size over the next five years with the recruitment of additional subject matter experts and technologists to swiftly bring innovative solutions to market, continue investing in customer satisfaction and grow Intelerad’s presence worldwide.

“I’ve had the pleasure of using Intelerad technology in my daily work for 17 years, the company truly understands the needs of the medical imaging community,” said radiologist Giovanni Artho, M.D., of the McGill University Health Centre (MUHC). “Intelerad solutions are highly versatile, extremely intuitive and constantly evolving to meet the needs of the market. They have a huge impact on efficiency and are critical for streamlining communication between care team members, which enables us to provide the highest quality patient care.”

For more information: www.intelerad.com

Related Content

Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
he U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast lesions, radiograph lung nodules and radiograph dental caries detection, postamendments class III devices (regulated under product code MYN), into class II (special controls), subject to premarket notification

Image courtesy of iCAD

News | Computer-Aided Detection Software | January 22, 2020
January 22, 2020 — The U.S.
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria
News | Artificial Intelligence | January 22, 2020
January 22, 2020 — Medical imaging technology company Oxipit ann
Hitachi Healthcare Americas announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio
News | Radiology Business | January 21, 2020
January 21, 2020 — Hitachi Healthcare Americas announced that it will create a new dedicated research and development
Sponsored Content | Videos | Enterprise Imaging | January 20, 2020
GE Healthcare's iCenter is a cloud-based management software that provides 24/7 visibility to customers' visual and o
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Konica Minolta Business Solutions, U.S.A., Inc. (Konica Minolta) announced its status as a Google Cloud Premier Partner.
News | Archive Cloud Storage | January 14, 2020
January 14, 2020 — ...
Videos | RSNA | January 13, 2020
ITN Editor Dave Fornell takes a tour of some of the most innovative new medical imaging technologies displayed on the